miRNEST 2.0: an integrative microRNA resource miRNEST 2.0, an integrative microRNA resource :: Browse



Data derived from PhenomiR


PubMed IDdiseasedisease classtissueexpressionfoldchange maxfoldchange mingenesstudy designmethod
17473300 Pancreatic cancer - 260350 Cancer pancreatic duct miRNA overexpression - 2.09 - Patient study phenotype-control miRNA microarray
17473300 Gastrointestinal - 0 (Pancreatitis - 0) Gastrointestinal pancreas miRNA overexpression - 3.04 - Patient study phenotype-control miRNA microarray
17563749 Cancer - 0 (Thyroid carcinoma, anaplastic - 0) Cancer thyroid gland miRNA downregulation - 2.1 - Patient study phenotype-control miRNA microarray
16966691 Pancreatic cancer - 260350 (Pancreatic endocrine tumors - 0) Cancer pancreas miRNA overexpression - 7.52 - Patient study phenotype-control miRNA microarray
17761882 Parkinson disease - 168600 Neurological midbrain miRNA downregulation - 1.40845 - Patient study phenotype-control quantitative PCR
16331254 Hepatocellular carcinoma - 114550 Cancer liver miRNA downregulation - - - Patient study phenotype-control miRNA microarray
18607389 Colorectal cancer - 114500 Cancer colorectum miRNA overexpression - 1.1 - Patient study phenotype-control quantitative PCR
17616669 Prostate cancer - 176807 Cancer prostate gland miRNA downregulation - - - Patient study phenotype-control miRNA microarray
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer, serous histotype - 0) Cancer ovary miRNA downregulation - 3.57143 - Patient study phenotype-control miRNA microarray
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer, endometrioid histotype - 0) Cancer ovary miRNA downregulation - 3.125 - Patient study phenotype-control miRNA microarray
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer, clear cell histotype - 0) Cancer ovary miRNA downregulation - 4.54545 - Patient study phenotype-control miRNA microarray
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer, mixed histotype - 0) Cancer ovary miRNA downregulation - 3.22581 - Patient study phenotype-control miRNA microarray
16461460 Pancreatic cancer - 260350 Cancer pancreas miRNA overexpression - - - Patient study phenotype-control miRNA microarray
17363563 Leukemia, acute myeloid - 601626 Cancer HL-60 cell miRNA downregulation - - - Cell culture study quantitative PCR
17875710 Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) Cancer ovary miRNA downregulation - 3.44828 - Patient study phenotype-control miRNA microarray
17363563 Leukemia, chronic myeloid - 608232 Cancer K-562 cell miRNA downregulation - - - Cell culture study quantitative PCR
17363563 Multiple myeloma - 254500 Cancer RPMI-8226 cell miRNA downregulation - - - Cell culture study quantitative PCR
17363563 Leukemia/lymphoma, chronic B-cell - 151400 Cancer lymphoma cell line miRNA downregulation - - - Cell culture study quantitative PCR
17363563 Glioblastoma multiforme, somatic - 137800 Cancer U-251 cell miRNA downregulation - 3.2 - Cell culture study quantitative PCR
16530703 Lung cancer - 211980 Cancer lung miRNA downregulation - - - Patient study phenotype-control miRNA microarray
18525125 Alzheimer disease, susceptibility to - 104300 Neurological cerebrospinal fluid miRNA overexpression - 1.89 - Patient study phenotype-phenotype quantitative PCR
16103053 Breast cancer - 114480 Cancer breast miRNA downregulation - - - Patient study phenotype-control miRNA microarray
16103053 Breast cancer - 114480 Cancer HS578 cell miRNA downregulation - - - Cell culture study miRNA microarray
18451233 Ovarian cancer - 604370 (Epithelial ovarian cancer, serous histotype - 0) Cancer ovary miRNA downregulation - 1.18 - Patient study phenotype-control miRNA microarray
15003116 - - NT2/D1 cell miRNA overexpression - - - Bioprocess study Northern Blot
17110380 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA overexpression - - ERBB2, ERBB3 Cell culture study Northern Blot
18381414 Squamous cell carcinoma, head and neck - 601400 (Oral squamous carcinoma (OSCC) - 0) Cancer HSC-3 cell miRNA downregulation - - - Cell culture study quantitative PCR
17606841 Cardiomyopathy, dilated - 115200 Cardiovascular left ventricle miRNA overexpression - 2.97 - Patient study phenotype-control miRNA microarray
17606841 - - left ventricle miRNA downregulation - 5.96 - Bioprocess study miRNA microarray
17942673 Muscular - 0 (muscular dystrophy, facioscapulohumeral - 0) Muscular muscle miRNA overexpression - 1.83 - Patient study phenotype-control miRNA microarray
18187662 Leukemia, acute myelogenous - 601626 Cancer blood miRNA downregulation - 1.92 - Patient study phenotype-control quantitative PCR
17942673 Muscular dystrophy, limb-girdle, type 2A - 253600 Muscular muscle miRNA overexpression - 1.76 - Patient study phenotype-control miRNA microarray
17942673 Muscular dystrophy, limb-girdle, type 2B - 253601 Muscular muscle miRNA overexpression - 1.83 - Patient study phenotype-control miRNA microarray
17942673 Miyoshi myopathy - 254130 Muscular muscle miRNA overexpression - 1.86 - Patient study phenotype-control miRNA microarray
17942673 Myopathy, nemaline, 3 - 161800 Muscular muscle miRNA overexpression - 2.56 - Patient study phenotype-control miRNA microarray
17942673 Muscular - 0 (Inclusion body myopathy - 0) Muscular muscle miRNA overexpression - 1.8 - Patient study phenotype-control miRNA microarray
18973228 Medulloblastoma - 155255 Cancer cerebellum miRNA downregulation - 5.88235 - Patient study phenotype-control quantitative PCR
17243163 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA overexpression - 2.44361 - Patient study phenotype-control miRNA microarray
16192569 Breast cancer - 114480 Cancer T-47D cell miRNA overexpression - 3.94 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer SK-BR-3 cell miRNA overexpression - 8.27 - Cell culture study quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA overexpression - 2.16 - Patient study phenotype-phenotype quantitative PCR
18337557 Leukemia, acute myeloid - 601626 Cancer bone marrow miRNA downregulation - 2.08333 - Patient study phenotype-phenotype quantitative PCR
18182067 Muscular - 0 (Uterine leiomyoma - 0) Muscular myoma cell miRNA downregulation - 1.2987 - Patient study phenotype-control miRNA microarray
17483472 Neuroblastoma - 256700 Cancer ganglion miRNA downregulation - - - Patient study phenotype-control quantitative PCR
16609010 Colorectal cancer - 114500 Cancer HCT-116 cell miRNA downregulation - 39.97 - Cell culture study miRNA microarray
18728182 Multiple myeloma - 254500 Cancer plasma cell miRNA downregulation - 4.54545 - Patient study phenotype-control miRNA microarray
16754881 Breast cancer - 114480 Cancer breast epithelium miRNA overexpression - - - Patient study phenotype-control array CGH
16754881 Melanoma and neural system tumor syndrome - 155755 Cancer cell culture miRNA downregulation - - - Cell culture study array CGH
16192569 Breast cancer - 114480 Cancer MCF-7 cell miRNA overexpression - 4.94 - Cell culture study quantitative PCR
17616669 Prostate cancer - 176807 Cancer PC-3 cell miRNA downregulation - - - Cell culture study miRNA microarray
16192569 Breast cancer - 114480 Cancer MDA-MB-231 cell miRNA overexpression - 2.35 - Cell culture study quantitative PCR
16192569 Breast cancer - 114480 Cancer MDA-MB-361 cell miRNA overexpression - 22.52 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PC-3 cell miRNA overexpression - 1.75 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer PPC-1 cell miRNA overexpression - 1.12 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer DU-145 cell miRNA overexpression - 2.18 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer Tsu-Pr1 cell miRNA downregulation - 2.38095 - Cell culture study quantitative PCR
16192569 Prostate cancer - 176807 Cancer LNCaP cell miRNA overexpression - 3.02 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 2.13 - Cell culture study quantitative PCR
16192569 Squamous cell carcinoma, head and neck - 601400 Cancer squamous cell carcinoma cell line miRNA overexpression - 2.59 - Cell culture study quantitative PCR
19022373 Leukemia, acute myelogenous - 601626 Cancer HL-60 cell miRNA overexpression - - - Patient study phenotype-phenotype miRNA microarray
18766170 Lung cancer - 211980 Cancer serum miRNA overexpression - - - Patient study phenotype-control deep sequencing
19030927 Gastrointestinal - 0 (Pancreatitis - 0) Gastrointestinal pancreas miRNA downregulation - 1.28205 - Patient study phenotype-control quantitative PCR
16737555 - - fibroblast miRNA overexpression - - - Bioprocess study miRNA microarray
16192569 Pancreatic cancer - 260350 Cancer PANC-1 cell miRNA overexpression - 3.67 - Cell culture study quantitative PCR
16192569 Lung cancer - 211980 Cancer lung cancer cell line miRNA overexpression - 2.87 - Cell culture study quantitative PCR
16192569 Hematological - 0 Hematological K-562 cell miRNA overexpression - 2.39 - Cell culture study quantitative PCR
18607389 - - embryo miRNA overexpression - 2.15 - Bioprocess study quantitative PCR
16192569 Lung cancer - 211980 Cancer A-549 cell miRNA overexpression - 3.63 - Cell culture study quantitative PCR
18375788 Lung cancer - 211980 Cancer lung miRNA overexpression - 1.0 - Patient study phenotype-control quantitative PCR